Related Experiment Videos
[Effect of human recombinant granulocyte colony-stimulating factor on mouse hematopoietic and lymphoid organs]
G V Karpova1, T I Fomina, E A Timina
1Institute of Pharmacology, Tomsk Scientific Center, Siberian Division, Russian Academy of Medical Sciences, pr. Lenina 3, Tomsk, 634028 Russia.
Eksperimental'Naia I Klinicheskaia Farmakologiia
|October 9, 2001
Abstract:
Experiments on intact CBA/CALac mice demonstrated that single (1.25 mg/kg) and repeated (0.125 and 1.25 mg/kg, 30 days) injections of recombinant human granulocyte colony stimulation factor lead to reversible dose-dependent granulocyte lineage hyperplasia in bone marrow, regenerative neutrophilic leukocytosis, and thrombocytosis in peripheric blood and to splenic granulo-, erythro-, and thrombocytopoiesis more expressed in males.